Fifth, previous CVOTs have suggested that the beneficial effects of GLP-1 RAs are primarily associated with long-acting agents such as liraglutide, semaglutide, and dulaglutide, rather than short-acting agents like exenatide and lixisenatide [17, 54, 56, 57, 68]
New data shows the DMN and reward circuits Cognitive Energetics & GLP-1: The Hidden Reason Behavior Change Feels Hard Discover how cognitive energetics explains why behavior change feels hardeven on GLP-1
doi: 10.1016/j.peptides.2019.170174
2010;(7):CD000940
Patients interested in inflammation, recovery, and whole-body wellness may also explore peptide therapy, regenerative medicine, longevity care, NAD+ IV Therapy, and concierge primary care